Arran Turnbull
Translational Oncology Research Team – Breast & Prostate Cancer
Research in a Nutshell
Our group aims to investigate the mechanisms of resistance to endocrine therapy in breast cancer and other treatments in both breast and prostate cancer and develop clinically-applicable approaches to identify patients who are at higher risk of disease progression or relapse.
People |
|
| Arran Turnbull | Group Leader |
| Prof Mike Dixon | Co-Group Leader |
| Dr Carlos Martinez-Perez | Postdoctoral Research Fellow |
| Ms Charlene Kay | Research Associate & PhD student |
| Zuzanna Gedziorowska | PhD student |
|
Monica McGill |
Research & Ethics Coordinator |
| Jillian VanOrsouw | Research Nurse |
Contact
Cancer Research Collaborations
- Professor Charles Perou, University of North Carolina
- Professor Lisa Carey, University of North Carolina
- Professor Bob Clarke, Hormel Institute
- Professor Val Brunton, University of Edinburgh
Partners and Funders (current)
- Breast Cancer Now
- Breast Cancer Institute
- The Urology Foundation
Scientific Themes
Breast cancer, prostate cancer, prediction of treatment response, mechanisms of treatment resistance
Technology expertise
RNA and DNA sequencing, bioinformatics, transcriptomics, mass spec